Discovery Labs receives new U.S. patent for pulmonary surfactant formulations Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.
News For DSCO From The Last 14 Days
Check below for free stories on DSCO the last two weeks.